Skip to main content
FENC
NASDAQ Life Sciences

Fennec Q3 2026: Net Product Sales Up 56% to $19.4M, Net Income $4.6M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$10.9
Mkt Cap
$382.232M
52W Low
$5.65
52W High
$13.25
52W Position info
93% above low
Off High info
18% below high
Rel. Volume info
1.6× avg
Market data snapshot near publication time

FENC sits 93% above its 52-week low of $5.65.

Summary

Fennec reported Q3 2026 net product sales of $19.4 million (up 56%) and net income of $4.6 million, with cash rising to $48.7 million. The quarter confirms profitable growth, though selling and marketing costs climbed to $10.1 million to support the expanded sales force.


Key Events · Earnings and Guidance · FENC

  • Q3 Net Product Sales Up 56%

    PEDMARK net product sales were $19,425K in Q3 2026 versus $12,462K a year earlier, a $6,963K increase; nine-month sales reached $51,697K, up 67% from $30,865K.

  • Company Swings to Profit

    Net income was $4,640K ($0.13 basic, $0.12 diluted) versus a $638K net loss in Q3 2025; nine-month net income was $6,814K and Adjusted EBITDA was $5,826K for the quarter.

  • Cash Grows to $48.7 Million

    Cash and cash equivalents rose to $48,684K from $36,788K at December 31, 2025, helped by $9,111K of operating cash flow; management says this funds the operating plan for at least twelve months.

  • Commercial Spend Jumps

    Selling and marketing expense rose to $10,050K from $6,513K on higher commercial headcount, while G&A fell to $3,912K from $5,449K after the Cipla patent litigation concluded.


Analysis · FENC · Life Sciences

The commercial ramp is now translating into real profit: net product sales of $19.4 million rose 56% year over year, operating income swung to $4.7 million from a small loss, and net income reached $4.6 million ($0.13 per basic share). Cash grew to $48.7 million from $36.8 million at year-end on $9.1 million of operating cash flow, and management says existing cash plus expected revenue funds the plan for at least twelve months. The trade-off is spending: selling and marketing jumped to $10.1 million from $6.5 million as the sales force was expanded, so the growth is being bought with higher commercial costs. New 10b5-1 selling plans for the CFO and a director are also disclosed, routine pre-planned activity rather than a change in the business.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, FENC was trading at $10.90 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $382.2M. The 52-week trading range was $5.65 to $13.25. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

FENC - Latest Insights

FENC
Nov 12, 2026, 6:06 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $10.64
Real-time Price: $11.62 info
Change: +$0.980 (+9%) info
Market Cap: $407.48M info
FENC
Sep 17, 2026, 4:03 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $10.78
Real-time Price: $11.62 info
Change: +$0.840 (+8%) info
Market Cap: $407.48M info
FENC
Sep 17, 2026, 7:30 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $10.55
Real-time Price: $11.62 info
Change: +$1.07 (+10%) info
Market Cap: $407.48M info
FENC
Aug 13, 2026, 4:03 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $12.06
Real-time Price: $11.62 info
Change: -$0.440 (-4%) info
Market Cap: $407.48M info
FENC
Jun 10, 2026, 5:19 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $8.70
Real-time Price: $11.62 info
Change: +$2.92 (+34%) info
Market Cap: $407.48M info